Correlation Between Lytus Technologies and Enfusion

Can any of the company-specific risk be diversified away by investing in both Lytus Technologies and Enfusion at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lytus Technologies and Enfusion into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lytus Technologies Holdings and Enfusion, you can compare the effects of market volatilities on Lytus Technologies and Enfusion and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lytus Technologies with a short position of Enfusion. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lytus Technologies and Enfusion.

Diversification Opportunities for Lytus Technologies and Enfusion

-0.68

Correlation Coefficient

Lytus Technologies  Enfusion

Excellent diversification

The 3 months correlation between Lytus and Enfusion is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Lytus Technologies Holdings and Enfusion in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enfusion and Lytus Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lytus Technologies Holdings are associated (or correlated) with Enfusion. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enfusion has no effect on the direction of Lytus Technologies i.e., Lytus Technologies and Enfusion go up and down completely randomly.

Pair Corralation between Lytus Technologies and Enfusion

Considering the 90-day investment horizon Lytus Technologies Holdings is expected to under-perform the Enfusion. In addition to that, Lytus Technologies is 2.14 times more volatile than Enfusion. It trades about -0.67 of its total potential returns per unit of risk. Enfusion is currently generating about 0.24 per unit of volatility. If you would invest  988.00  in Enfusion on September 15, 2024 and sell it today you would earn a total of  77.00  from holding Enfusion or generate 7.79% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Lytus Technologies Holdings  vs.  Enfusion

Lytus Technologies

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Lytus Technologies Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Enfusion

Risk-Adjusted Performance

15 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Enfusion are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of very abnormal technical and fundamental indicators, Enfusion displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Lytus Technologies and Enfusion

The main advantage of trading using opposite Lytus Technologies and Enfusion positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lytus Technologies position performs unexpectedly, Enfusion can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enfusion will offset losses from the drop in Enfusion's long position.

The idea behind Lytus Technologies Holdings and Enfusion pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.